Detalhe da pesquisa
1.
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).
BMC Cancer;
20(1): 1185, 2020 Dec 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33272262
2.
Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.
BMC Cancer;
18(1): 333, 2018 03 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29587656
3.
SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.
BMC Cancer;
15: 300, 2015 Apr 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25928859
4.
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
JTO Clin Res Rep;
5(4): 100626, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38586301
5.
Treatment choice in EGFR-mutant non-small-cell lung cancer.
Lancet Oncol;
18(11): 1425-1426, 2017 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28958503
6.
Comparative efficacy and safety of multitarget angiogenesis inhibitor combined with immune checkpoint inhibitor and nivolumab monotherapy as second-line or beyond for advanced lung adenocarcinoma in driver-negative patients: a retrospective comparative cohort study.
Transl Lung Cancer Res;
12(5): 1108-1121, 2023 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37323173
7.
Response of an HER2-Mutated NSCLC Patient to Trastuzumab Deruxtecan and Monitoring of Plasma ctDNA Levels by Liquid Biopsy.
Curr Oncol;
30(2): 1692-1698, 2023 01 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36826091
8.
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report.
Curr Oncol;
30(10): 8865-8871, 2023 09 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37887540
9.
Combination of the platelet-to-lymphocyte ratio and fibrinogen may predict 5-year overall survival of patient in non-small cell lung cancer treated with surgery.
J Thorac Dis;
15(12): 6967-6975, 2023 Dec 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38249876
10.
Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study.
J Geriatr Oncol;
14(1): 101394, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36323612
11.
A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer.
Transl Lung Cancer Res;
11(1): 75-86, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35242629
12.
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions.
Eur J Cancer;
170: 106-118, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35598358
13.
Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC).
Transl Lung Cancer Res;
10(11): 4106-4119, 2021 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35004242
14.
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
Transl Lung Cancer Res;
10(7): 3093-3105, 2021 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34430350
15.
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV.
Clin Med Insights Oncol;
14: 1179554920951358, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32884390
16.
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study.
Cancers (Basel);
12(8)2020 Aug 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32824580
17.
Comparability of microarray data between amplified and non amplified RNA in colorectal carcinoma.
J Biomed Biotechnol;
2009: 837170, 2009.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19826639
18.
Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
Anticancer Res;
29(1): 67-74, 2009 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19331134
19.
Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy.
Int J Cancer;
123(9): 2120-9, 2008 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18697200
20.
Dynamic change of CD8+ T cell: immunotherapy fate tell?
Transl Lung Cancer Res;
12(5): 944-947, 2023 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37323171